ABSTRACT The Human T-Lymphotropic Virus type 1 (HTLV-1) affects up to 10 million
people worldwide. It is directly associated to one of the most aggressive T cell malignancies …

We estimated that at least 5–10 million individuals are infected with HTLV-1. Importantly, this
number is based on the study of nearly 1.5 billion people living in known human T-cell …

This article addresses the Human T-lymphotropic virus (HTLV). This subject comprises the
Clinical Protocol and Therapeutic Guidelines for Comprehensive Care for People with …

O artigo aborda a infecção pelo vírus linfotrópico de células T humanas (human T
lymphotropic virus, HTLV), tema contemplado no Protocolo Clínico e Diretrizes Terapêuticas …

Specific pathogen free (SPF) macaques provide valuable animal models for biomedical
research. In 1989, the National Center for Research Resources [now Office of Research …

Serological tests have been widely used for detecting human T-cell lymphotropic virus type
1/2 (HTLV-1/2) antibodies in the endemic areas, but their performance in low-risk …

A multi-epitope protein expressed in a prokaryotic system, including epitopes of Env, Gag,
and Tax proteins of both HTLV-1 and HTLV-2 was characterized for HTLV-1/2 serological …

Background: indeterminate Western blot (WB) patterns are a major concern for diagnosis of
human T-cell lymphotropic virus type 1 (HTLV-1) infection, even in non-endemic areas …

Con el objetivo de reducir el número de resultados falsos reactivos al determinar los
anticuerpos contra HTLV-1/2, se evaluaron algoritmos alternativos. De 20 210 muestras …

Human T‐cell lymphoma virus (HTLV) has been associated with various disease types.
Since the discovery of the virus in 1980, seven subtypes of the virus have been identified …